These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 7024764)

  • 21. [Effect of sensit on the course of ischemic heart disease].
    Nesvetov VN; Gorshkov VA; Kuliamin VI; Buskin VD
    Sov Med; 1988; (3):57-61. PubMed ID: 3413552
    [No Abstract]   [Full Text] [Related]  

  • 22. [Causes and treatment of coronary failure].
    Kutscha W
    Fortschr Med Suppl; 1986; 3():15-8. PubMed ID: 2870963
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effect of the calcium antagonist fendiline on digitalis-induced ischemic reactions in the ECG].
    Kababgi MD; Schneider KW; Deeg P
    Med Welt; 1980 Jun; 31(25):959-62. PubMed ID: 7421525
    [No Abstract]   [Full Text] [Related]  

  • 24. [Evaluation of a multicenter study on the new coronary vasodilator agent Sensit].
    Meza E; Orozco-Mafud A
    Prensa Med Mex; 1977; 42(1-2):78-83. PubMed ID: 331301
    [No Abstract]   [Full Text] [Related]  

  • 25. [Calmodulin antagonists in general practice. Evaluation of the side-effect spectrum].
    Kartnik G
    Fortschr Med Suppl; 1986; 3():18-9. PubMed ID: 2870964
    [No Abstract]   [Full Text] [Related]  

  • 26. [Treatment of patients with ischemic heart diseases using senzit].
    Zamotaev IP; Venediktova MG; Zakharova GIu
    Klin Med (Mosk); 1988 Aug; 66(8):68-71. PubMed ID: 3193737
    [No Abstract]   [Full Text] [Related]  

  • 27. [Value of fendiline in the treatment of patients with stable angina pectoris].
    Markiewicz M; Wysokiński A; Rymar B; Trojnar R
    Pol Tyg Lek; 1987 Nov; 42(46):1456-8. PubMed ID: 3328180
    [No Abstract]   [Full Text] [Related]  

  • 28. [New drug (Sensit) for the treatment of coronary disease in a double blind test].
    Pillen D
    Fortschr Med; 1974 Jun; 92(16):709-11. PubMed ID: 4600940
    [No Abstract]   [Full Text] [Related]  

  • 29. [Statistical evaluation of a cooperative study toward investigation of the effectiveness of the coronary stimulant dilazep in ischemic heart disease. 3. Influence of the duration of therapy and co-medication on the therapeutic result. Secondary effects and discontinuation of therapy].
    Schneider VB; Feldmann U; von Brachel H; Schnitker J; Gelbhaar H
    Arzneimittelforschung; 1974 Nov; 24(11A Suppl):1873-9. PubMed ID: 4155950
    [No Abstract]   [Full Text] [Related]  

  • 30. [Therapy of coronary heart disease with calcium antagonists in clinical practice].
    Bleifeld W; Spokojny A
    Med Welt; 1983 Nov; 34(47):1335-9. PubMed ID: 6656569
    [No Abstract]   [Full Text] [Related]  

  • 31. [Indications for use of calcium antagonists].
    Lehmann HU; Hochrein H
    Med Klin; 1980 Apr; 75(8):288-94. PubMed ID: 6993902
    [No Abstract]   [Full Text] [Related]  

  • 32. [Drug therapy of coronary ischemia].
    Ollagnier M
    Soins Cardiol; 1985 Dec; (34):3-4. PubMed ID: 3854550
    [No Abstract]   [Full Text] [Related]  

  • 33. [Drug therapy of coronary insufficiency].
    Hilger HH; Tauchert M
    Internist (Berl); 1977 Jun; 18(6):315-21. PubMed ID: 18424
    [No Abstract]   [Full Text] [Related]  

  • 34. [Statistical evaluation of a cooperative study toward investigation of the effectiveness of the coronary stimulant dilazep in ischemic heart disease. 4. Results of a summarizing evaluation with factor analysis and multiple regression analysis].
    Schneider VB; Feldmann U; von Brachel H; Schnitker J; Gelbhaar H
    Arzneimittelforschung; 1974 Nov; 24(11A Suppl):1879-93. PubMed ID: 4155951
    [No Abstract]   [Full Text] [Related]  

  • 35. [Therapy of coronary insufficiency with a combination of a coronary dilator and a beta-adrenergic blockader].
    Grujić M; Perinović M
    Med Arh; 1972; 26(4):267-70. PubMed ID: 4405711
    [No Abstract]   [Full Text] [Related]  

  • 36. [KHK and treatment with calcium antagonists].
    Internist (Berl); 1996 Jan; 37(1 Suppl Khk Und D):1-8. PubMed ID: 9541669
    [No Abstract]   [Full Text] [Related]  

  • 37. Fendiline: a review of its basic pharmacological and clinical properties.
    Bayer R; Mannhold R
    Pharmatherapeutica; 1987; 5(2):103-36. PubMed ID: 3310016
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hemodynamic and humoral effects of fendiline, a calcium antagonist drug, in idiopathic hypertension patients].
    Castellano M; Beschi M; Muiesan ML; Romanelli G; Muiesan G
    Cardiologia; 1984; 29(7-8):359-66. PubMed ID: 6542415
    [No Abstract]   [Full Text] [Related]  

  • 39. [Value of the combination of trimetazidine and a calcium inhibitor in the treatment of chronic coronary insufficiency. Double-blind controlled study versus placebo].
    Brochier M; Demange J; Ducloux G; Monpère C; Warin JF
    Ann Cardiol Angeiol (Paris); 1986 Jan; 35(1):49-56. PubMed ID: 3516053
    [No Abstract]   [Full Text] [Related]  

  • 40. [Calcium channel blockers. Review and attempt at classification].
    van Zwieten PA; Timmermans PB
    Rev Esp Cardiol; 1984; 37(5):322-9. PubMed ID: 6387828
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.